knowledge -WSS

knowledge

author：entertainment 2025-10-01 21:33:25 - browse：425

Patient treated with Impella in the heart. -- health tech coverage from STAT — Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. Business Wire

The Food and Drug Administration is following through on its promise to regulate more health software tools, starting with a public reprimand of Johnson & Johnson’s heart pump company, Abiomed.

Abiomed, which was bought by Johnson & Johnson late last year for $16.6 billion, sells devices for heart failure patients as well as patient monitoring software. The FDA published a warning letter on Wednesday telling the company it should have submitted its software for approval before putting it on the market. The agency also took issue with Abiomed’s failure to report various problems with its heart pumps.

The letter comes a year after the Food and Drug Administration announced its intention to regulate more health software tools, sending the industry into an uproar.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： CDC advisory panel says seniors 'may' get RSV vaccine

leisure time

hotspot

WSS

A Theranos scientist

AstraZeneca bets AAV gene therapy will still deliver the goods

Radiation, mainstay of cancer treatment, begins a fade

Departing Stanford president retracts two papers

How to make Best Hospitals ratings actually useful for patients

AstraZeneca bets AAV gene therapy will still deliver the goods

explore

knowledge

explore

In age of alternative facts, a scholarly course on calling out crap

What AAP's gender

Medical records are filled with copy

As pharma fights Medicare drug negotiation, hospitals, docs silent

Peter Hotez and the public health issue of online harassment

How Long Island became the ‘eugenics capital of the world’

Moonlake's readout produced a cash windfall. Risks remain

Manchin plays down potential 3rd

The cancer drug shortage isn’t new — and neither are the solutions

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

entertainment

Why you get paid to donate plasma but not blood

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

A look at other Americans who have crossed into North Korea over the years

Search resumes for 2 missing children washed away with mom in deadly Pennsylvania flash flood

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

leisure time

hotspot

entertainment

focus